SYNSAM 📈 Synsam AB - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0016829709
SYNSAM: Glasses, Sunglasses, Sports Glasses, Contact Lenses, Eye Exams
Synsam AB, a publicly traded company, is a leading optical retailer in the Nordic Region, operating a diverse range of stores and ecommerce platforms across Sweden, Denmark, Norway, Iceland, the Faroe Islands, and Finland. The company's product portfolio includes a wide selection of glasses, sunglasses, sports glasses, and contact lenses, catering to various customer needs and preferences. Additionally, Synsam offers glasses and contact lens subscriptions, as well as comprehensive eye examination services, all under the Synsam Lifestyle brand, which emphasizes a holistic approach to eye care and vision correction.
With a history dating back to 1968, Synsam AB has established itself as a trusted and reputable player in the Nordic optical retail market. The company's business model is built around a combination of directly owned and franchised stores, allowing for a strong physical presence in key markets, while also leveraging ecommerce channels to reach a broader customer base. This multi-channel approach enables Synsam to provide convenient and accessible eye care solutions to customers across the region. As a publicly traded company, Synsam AB is committed to transparency and accountability, with its common stock listed under the ISIN code SE0016829709, and classified under the GICS Sub Industry category of Life Sciences Tools & Services.
As a major player in the Nordic optical retail market, Synsam AB is well-positioned to capitalize on growing demand for eye care services and products. The company's website, https://www.synsamgroup.com, provides customers with a user-friendly platform to browse products, book eye examinations, and access information on various eye care services. With its strong brand presence, extensive product range, and commitment to customer satisfaction, Synsam AB is a key player in the Nordic Region's optical retail landscape, with a focus on delivering high-quality eye care solutions to customers across the region.
Additional Sources for SYNSAM Stock
SYNSAM Stock Overview
Market Cap in USD | 611m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception |
SYNSAM Stock Ratings
Growth 5y | -24.7% |
Fundamental | 70.3% |
Dividend | 49.1% |
Rel. Strength Industry | -25.7 |
Analysts | - |
Fair Price Momentum | 40.01 SEK |
Fair Price DCF | 166.97 SEK |
SYNSAM Dividends
Dividend Yield 12m | 4.26% |
Yield on Cost 5y | 3.69% |
Annual Growth 5y | 0.00% |
Payout Consistency | 98.3% |
SYNSAM Growth Ratios
Growth Correlation 3m | -86.5% |
Growth Correlation 12m | -29% |
Growth Correlation 5y | -38.6% |
CAGR 5y | -3.87% |
CAGR/Mean DD 5y | -0.13 |
Sharpe Ratio 12m | 0.09 |
Alpha | -17.29 |
Beta | 0.67 |
Volatility | 34.10% |
Current Volume | 256.8k |
Average Volume 20d | 272.6k |
As of December 21, 2024, the stock is trading at SEK 43.00 with a total of 256,835 shares traded.
Over the past week, the price has changed by -0.47%, over one month by +2.67%, over three months by -12.33% and over the past year by +1.73%.
Yes, based on ValueRay Fundamental Analyses, Synsam AB (ST:SYNSAM) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 70.26 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SYNSAM as of December 2024 is 40.01. This means that SYNSAM is currently overvalued and has a potential downside of -6.95%.
Synsam AB has no consensus analysts rating.
According to ValueRays Forecast Model, SYNSAM Synsam AB will be worth about 43.7 in December 2025. The stock is currently trading at 43.00. This means that the stock has a potential upside of +1.63%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 61.8 | 43.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 43.7 | 1.6% |